Breaking News- EECP for Long COVID treatment.
Read Press Release

A Practical Approach to Selecting EECP Patients

A Practical Approach to Selecting EECP Patients
Written by: Jennifer

This post is an excerpt from an article originally published in 2006 by the Nature Clinic Practice, Cardiovascular Medicine. Click the link at the bottom to read the full article.

Over the past decade, the frequency of use of enhanced external counterpulsation (EECP) has increased in patients with angina, irrespective of medical therapy and coronary revascularization status.

Many patients referred for EECP have one or more comorbidities that could affect this treatment’s efficacy, safety, or both. By use of data from more than 8,000 patients enrolled in the International EECP Patient Registry, we provide practical guidelines for the selection and treatment of patients. We have focused on considerations for patients who have one or more of the following characteristics: age older than 75 years, diabetes, obesity, heart failure, and peripheral vascular disease. We have also reviewed outcomes and treatment recommendations for individuals with poor diastolic augmentation during treatment, for those with atrial fibrillation or pacemakers, and for those receiving anticoagulation therapy. Lastly, we examined relevant data regarding extended courses of EECP, repeat therapy, or both. While clinical studies have demonstrated the usefulness of EECP in selected patients, these guidelines permit recommendations for the extended application of this important treatment to subsets of patients excluded from clinical trials.

More EECP Resources

EECP for Ischemic Heart Disease: What’s Behind the Curtain?

EECP is shown to reduce angina and improve myocardial ischemia.

Read More

Immediate & Long-term EECP Outcomes on Chronic Stable Refractory Angina

A high proportion of patients gain symptomatic benefit from EECP.

Read More

Evidence for EECP Therapy as Heart Failure Management Tool

Learn about balloon counterpulsation as a therapy for cardiogenic shock.

Read More